| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,915 |
2,575 |
$186K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14,075 |
13,916 |
$175K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,918 |
5,140 |
$173K |
| 84443 |
Thyroid stimulating hormone (TSH) |
17,659 |
17,289 |
$130K |
| 80053 |
Comprehensive metabolic panel |
27,357 |
26,049 |
$92K |
| 80061 |
Lipid panel |
19,660 |
19,468 |
$86K |
| 85027 |
|
24,980 |
23,793 |
$68K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17,943 |
17,697 |
$61K |
| 82607 |
|
10,052 |
9,765 |
$54K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,445 |
2,170 |
$47K |
| 83970 |
|
3,007 |
2,966 |
$35K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,163 |
1,074 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,023 |
1,018 |
$22K |
| 82728 |
|
4,552 |
4,261 |
$21K |
| 84439 |
|
5,130 |
5,040 |
$20K |
| 82746 |
|
3,056 |
2,908 |
$16K |
| 83550 |
|
5,436 |
5,110 |
$16K |
| ATP17 |
|
5,764 |
5,756 |
$15K |
| 84153 |
|
1,603 |
1,565 |
$14K |
| 82043 |
|
6,903 |
6,837 |
$12K |
| 83540 |
|
5,444 |
5,116 |
$12K |
| 82570 |
|
6,864 |
6,799 |
$12K |
| 86803 |
|
1,100 |
1,087 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,712 |
2,552 |
$9K |
| ATP14 |
|
3,996 |
3,790 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,623 |
3,445 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
118 |
117 |
$6K |
| 86140 |
|
2,501 |
2,452 |
$6K |
| 83735 |
|
3,015 |
2,773 |
$6K |
| 81003 |
|
4,694 |
4,629 |
$5K |
| 85651 |
|
2,584 |
2,535 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,244 |
1,226 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
133 |
132 |
$3K |
| 84480 |
|
488 |
480 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
126 |
123 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
126 |
123 |
$3K |
| 86769 |
|
116 |
113 |
$3K |
| ATP15 |
|
1,386 |
1,269 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
142 |
140 |
$3K |
| 83615 |
|
2,602 |
2,213 |
$3K |
| 86703 |
|
303 |
301 |
$3K |
| 80076 |
|
952 |
927 |
$3K |
| ATP18 |
|
769 |
768 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
207 |
148 |
$2K |
| 87088 |
|
701 |
669 |
$2K |
| 81001 |
|
1,669 |
1,634 |
$2K |
| 87186 |
|
595 |
572 |
$2K |
| 83721 |
|
1,945 |
1,889 |
$2K |
| 82378 |
|
248 |
218 |
$2K |
| 84550 |
|
1,232 |
1,207 |
$1K |
| ATP08 |
|
689 |
655 |
$1K |
| 82248 |
|
855 |
847 |
$1K |
| 84100 |
|
879 |
863 |
$625.05 |
| 80069 |
|
310 |
304 |
$463.57 |
| 81015 |
|
1,250 |
1,212 |
$306.69 |
| 82550 |
|
111 |
110 |
$258.30 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
33 |
30 |
$256.55 |
| 87480 |
|
14 |
13 |
$248.99 |
| 87510 |
|
14 |
13 |
$248.99 |
| 87660 |
|
14 |
13 |
$248.99 |
| 82150 |
|
56 |
52 |
$128.57 |
| 85045 |
|
98 |
90 |
$118.39 |
| 86780 |
|
12 |
12 |
$87.38 |
| 36415 |
Collection of venous blood by venipuncture |
320 |
301 |
$71.00 |
| ATP13 |
|
13 |
13 |
$55.20 |
| ATP10 |
|
13 |
12 |
$45.45 |
| 84460 |
|
12 |
12 |
$18.03 |
| 84436 |
|
12 |
12 |
$16.54 |
| 82040 |
|
15 |
14 |
$10.57 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
76 |
76 |
$0.00 |